| 18.09 12:31 | EQS-News: Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis |
| 18.09 12:31 | EQS-News: Immunic Presents Key Vidofludimus -2- |
| 18.09 12:30 | EQS-News: Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis |
| 18.09 12:30 | EQS-News: Immunic Presents Key Vidofludimus -2- |
| 18.09 12:30 | dpa-AFX: EQS-News: Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis (english) |
| 04.09 12:31 | EQS-News: Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome |
| 04.09 12:31 | EQS-News: Immunic Announces First Patient -2- |
| 04.09 12:30 | EQS-News: Immunic Announces First Patient -2- |
| 04.09 12:30 | EQS-News: Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome |
| 04.09 12:30 | dpa-AFX: EQS-News: Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome (english) |
| 28.08 12:31 | EQS-News: Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September |
| 28.08 12:31 | EQS-News: Immunic to Host Multiple Sclerosis R&D -2- |
| 28.08 12:30 | dpa-AFX: EQS-News: Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September (english) |
| 28.08 12:30 | EQS-News: Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September |
| 28.08 12:30 | EQS-News: Immunic to Host Multiple Sclerosis R&D -2- |
| 08.08 12:31 | EQS-News: Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update |
| 08.08 12:31 | EQS-News: Immunic, Inc. Reports Second Quarter -2- |
| 08.08 12:30 | EQS-News: Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update |
| 08.08 12:30 | EQS-News: Immunic, Inc. Reports Second Quarter -2- |
| 08.08 12:30 | dpa-AFX: EQS-News: Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update (english) |
|
|
